MedTrace Logo

Pulmonary Complications of Hematopoietic Stem Cell Transplantation

NCT00837681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2017-02-27

No results posted yet for this study

Summary

The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately develop therapies to prevent or treat this lung disease.

Conditions

Sponsors & Collaborators

  • Karen Wood

    lead OTHER

Principal Investigators

  • Karen Wood, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2016-07-08
Completion
2016-07-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00837681 on ClinicalTrials.gov